Case report of fatal immune-mediated myocarditis following treatment with davoceticept (ALPN-202), a PD-L1-dependent CD28 costimulator and dual PD-L1/CTLA-4 checkpoint inhibitor, i... by Amanda Enstrom, Diwakar Davar, Nehal Lakhani, Heidi LeBlanc, Stanford L Peng, Frank Schneider, Heather Thomas, Michael J Chisamore, Allison Naumovski, Ludimila Cavalcante, Sreenivasa Chandana, Joseph Schmalz, Krisztina Lengyel

Get full text

Abemaciclib in combination with pembrolizumab for HR+, HER2− metastatic breast cancer: Phase 1b study by Hope S. Rugo, Peter Kabos, J. Thad Beck, Guy Jerusalem, Hans Wildiers, Elena Sevillano, Luis Paz-Ares, Michael J. Chisamore, Sonya C. Chapman, Anwar M. Hossain, Yanyun Chen, Sara M. Tolaney

Get full text

Phase I studies of davoceticept (ALPN-202), a PD-L1-dependent CD28 co-stimulator and dual PD-L1/CTLA-4 inhibitor, as monotherapy and in combination with pembrolizumab in advanced s... by Mark Voskoboynik, Justin Moser, Mario Sznol, Amita Patnaik, Amanda Enstrom, Diwakar Davar, Michael Millward, Rachel E Sanborn, Meredith McKean, Justin F Gainor, Nehal Lakhani, Heidi LeBlanc, Stanford L Peng, Heather Thomas, Lori Blanchfield, Michael J Chisamore, Allison Naumovski, Ludimila Cavalcante, Jaspreet S Grewal, Ajita Narayan

Get full text

First-in-human phase I study of the OX40 agonist GSK3174998 with or without pembrolizumab in patients with selected advanced solid tumors (ENGAGE-1) by Stephane Champiat, Aurélien Marabelle, Anna Spreafico, Mehmet Altan, Todd M Bauer, Osama Rahma, Karen A Autio, Neeta Somaiah, Meredith McKean, Aaron R Hansen, Jan H M Schellens, Willeke Ros, F Stephen Hodi, Jeffrey S Weber, John V Heymach, Herbert Struemper, Sandrine Aspeslagh, Daniel C Cho, Jennifer K Litton, Axel Hoos, Vincent K Lam, Emmett V Schmidt, Sophie Postel-Vinay, Frans L Opdam, Elaine M Paul, Christoph M Ahlers, Helen Zhou, Shelby A Gorman, Maura Watmuff, Kaitlin M Yablonski, Niranjan Yanamandra, Michael J Chisamore

Get full text